Pediatric Transplant Symposium

La Dre Lorraine Hamiwka est heureuse d’organiser le tout premier , est heureuse d’organiser le tout premier symposium multidisciplinaire et multi-organes sur la transplantation pédiatrique, qui se tiendra en format hybride, avec un volet en personne à Calgary, en Alberta.

Ce symposium vise à mettre en évidence les opportunités actuelles et émergentes pour mettre en œuvre les dernières preuves en matière de recherche sur la transplantation pédiatrique en Alberta et à l’international. Il comprendra également un conférencier principal, des sessions supplémentaires, des tables rondes, des sessions interactives et des moments dédiés au réseautage. Ce programme rassemble des chercheurs de renommée mondiale (d’Alberta, du Canada et de l’international), des professionnels de la santé, ainsi que des partenaires de recherche impliquant des patients, des familles et des donneurs, qui sont à la pointe de la recherche sur la transplantation pédiatrique. Ce forum mettra en évidence les principaux développements scientifiques qui ont permis d’améliorer les soins, le traitement et le bien-être des patients et de leurs familles avant, pendant et après une greffe d’organe. Cet événement est gratuit.

Session 4: ABO-incompatible Heart Transplant in Infants: From Urgent Band-aid to Clinical Standard

Cette session commencera par une présentation de la Dre Lori West sur ABO-incompatible transplantation: then, now, and tomorrow (14:30–14:50). Elle sera suivie d’une présentation du Dr Simon Urschel sur Expanding Clinical Experience and Immunological Considerations (14:50–15:10), , puis d’une présentation de la Dre Anne Halpin sur Inequities in Transplant Access: ABO Offers Opportunities (15:10–15:30). La session sera modérée par les docteurs Tom Blydt-Hansen et Ngan Lam.
Inscrivez-vous ci-dessous pour vous assurer de participer à ces discussions éclairantes!

Modérateurs

Conférenciers

Image d'une femme en chemise et cravate

À propos de Dr. Lori West

Dr. Lori West is a Professor of Pediatrics, Surgery, Medical Microbiology/Immunology and Laboratory Medicine/Pathology at the University of Alberta and Director of the Alberta Transplant Institute. A clinician-scientist, she has longstanding interest and expertise in pediatric heart transplantation and transplant immunology, particularly related to ABO glycoimmunology. Her pioneering work on crossing ABO-barriers led to global impact on infant heart transplantation. Dr. West is also the founding Director of the Canadian Donation and Transplantation Research Program, a national research coalition funded since 2013 by the Canadian Institutes of Health Research. Together with founding co-Director Dr. Marie-Josée Hébert, the CDTRP framework has grown to encompass collaborations in all streams of research with hundreds of investigators at 37 sites across Canada. Dr. West previously held the Tier 1 Canada Research Chair in Heart Transplantation. She is past-president of the International Society of Heart and Lung Transplantation and the Canadian Society of Transplantation, immediate past-chair of the Women in Transplantation international initiative of The Transplantation Society, and served as a member of the Board of Directors of the American Society of Transplantation. She is also an honorary lifetime member of the British Society of Transplantation. A Fellow of both the Royal Society of Canada and the Canadian Academy of Health Sciences, Dr. West was inducted as an Officer of the Order of Canada in 2022.
Image d'une femme en chemise et cravate

À propos de Dr. Simon Urschel

Dr. Simon Urschel is a Pediatric Cardiologist and Immunologist and Director of the Pediatric Heart Transplant program at the Stollery Children’s Hospital, providing heart transplantation for all western Canadian Provinces and Territories and Professor of Pediatrics, Medical Microbiology and Immunology at the University of Alberta.
He received his training in Pediatrics, congenital and acquired immunodeficiencies and Pediatric Cardiology at the Ludwig Maximilians University in Munich, Germany. He worked as a specialist for pediatric heart transplantation in Munich before coming to Edmonton in 2008 for a research term in Transplant Immunology followed by a faculty position in the Department of Pediatrics. Dr. Urschel’s research focuses on the immature immune system of early childhood and how natural weaknesses of the immune response can improve outcomes of organ transplantation. His work on blood group incompatible heart transplantation and desensitization therapies has contributed to establish these techniques as a standard option in many parts of the world resulting in shorter wait times, better utilization of donor organs and improved survival after heart transplantation. His second research focus is on quality of life, neurocognitive outcomes and mental health after pediatric transplantation. This includes studies and interventions on social disparities, improved patient integration into care, and communication strategies to reach teenagers to contribute in their medical management.
Dr Urschel serves in many leadership roles on international, national, provincial and local organizations including the Board of Directors of the International Society for Heart and Lung Transplantation (ISHLT), leadership roles in the Pediatric Heart Transplant Society (PHTS), the Canadian Donation and Transplant Research Program (CDTRP), the Alberta Transplant Institute (ATI) and Transplant Services Alberta.
Image d'une femme en chemise et cravate

À propos de Dre. Anne Halpin

Dr. Anne Halpin is Clinical Fellow at the University of Alberta Hospital (Alberta Precision Laboratories). She is also an Assistant Clinical Professor in the Department of Laboratory Medicine & Pathology at the University of Alberta. She completed a BSc in Medical Laboratory Science at the University of Alberta as well as received an MSc in Public Health from Trinity College, Dublin. She recently completed a PhD in the laboratory of Dr. Lori West, also at the University of Alberta, where her research focused on immune risk assessment in pediatric heart transplantation related to HLA, non-HLA, and ABO antibodies.